Fact CheckerSign in

NCT07616323Not yet recruiting

Screening LUMBAR Syndrome in Infants With Infantile Hemangiomas

Diameter Threshold for Screening LUMBAR Syndrome in Infants With Lumbosacral, Sacrococcygeal, Perineal, and Gluteal Infantile Hemangiomas: A Prospective Multicenter Cohort Study

Source: ClinicalTrials.gov · Last updated 1 Jun 2026

Brief summary (registry, in English)

The objective of this study is to determine the maximal diameter threshold at which infants with lumbosacral, sacrococcygeal, perineal, gluteal, or lower-limb extending infantile hemangiomas should undergo screening for LUMBAR syndrome.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
70 (estimated)
First submitted
21 May 2026
Start date
1 Jun 2026
Primary completion date
30 Jun 2027
Lead sponsor
West China Hospital
NCT number
NCT07616323

What you commit to

  • Study type: Observational
  • Planned participants: 70
  • From 1 Jun 2026 to the primary completion date, 30 Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previously diagnosed genetic or congenital syndrome unrelated to LUMBAR syndrome, which may independently explain the detected anomalies.

Other illness

  • Any condition judged by the investigators to be unsuitable for study participation.

Other

  • Vascular anomaly other than infantile hemangioma, such as venous malformation, lymphatic malformation, arteriovenous malformation, or congenital hemangioma.
  • Incomplete clinical data preventing accurate measurement of lesion diameter.
  • Refusal of participation or refusal to complete core screening examinations.

Who the study is looking for

  • Clinically diagnosed infantile hemangioma.
  • Lesion located in at least one of the following regions: lumbosacral region, sacrococcygeal region, gluteal region, perineal region, perianal region, external genital region, or continuous extension to the lower limb.
  • Maximal lesion diameter ≥2.0 cm.
  • Written informed consent obtained from the parents or legal guardians.

Age in the registry: 0 years to 10 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
West China Hospital of Sichuan University
Coordinator of this site? Confirm its status
ChengduChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.